Historical record - last NADAC effective date: 6/23/2021
Product Information
ALL DAY PAIN RLF 220 MG CAPLET is a generic product labeled by Topco Associates LLC, priced at $0.0551 per EA under NDC 36800036862. Its NADAC has been published 397 times since Nov 28, 2013.
FDA first approved this application on Jan 13, 1997.
Strength
220 mg/1
Manufacturer
Topco Associates LLCNDC
36800036862
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/23/2021
Active Ingredients
NAPROXEN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA074661FDA Approved
1/13/1997
On Market Since
1/14/1997
Pharmacological Classes
Price Statistics
The NADAC for ALL DAY PAIN RLF 220 MG CAPLET has been published 397 times since Nov 28, 2013, and over the history we have for it it has risen 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0551 per EA |
|---|---|
| All-time high | $0.0600 (Aug 12, 2015) |
| All-time low | $0.0513 (Nov 28, 2013) |
| Median price | $0.0554 |
| Average price | $0.0556 |
| Largest weekly change | +7.9% (Aug 17, 2016) |
| Weeks tracked | 397 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+7.4%
Last surveyed Jun 30, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Topco Associates LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naproxen Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALL DAY PAIN RLF 220 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for ALL DAY PAIN RLF 220 MG CAPLET, manufactured by Topco Associates LLC, is $0.0551 per EA (NDC 36800036862), effective Jun 30, 2021.
How has the price of ALL DAY PAIN RLF 220 MG CAPLET changed over time?
Over the history we have for it, the NADAC for ALL DAY PAIN RLF 220 MG CAPLET has risen 7.4%. It has been tracked across 397 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALL DAY PAIN RLF 220 MG CAPLET?
Since Nov 28, 2013, the NADAC for ALL DAY PAIN RLF 220 MG CAPLET has ranged from a low of $0.0513 (Nov 28, 2013) to a high of $0.0600 (Aug 12, 2015), with a median of $0.0554 per EA.
Are there cheaper alternatives to ALL DAY PAIN RLF 220 MG CAPLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALL DAY PAIN RLF 220 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALL DAY PAIN RLF 220 MG CAPLET?
ALL DAY PAIN RLF 220 MG CAPLET (NDC 36800036862) is labeled by Topco Associates LLC, and CMS classifies it as a generic product.